Shian‐Shiang Wang
Papers
2
Total Citations
25
H-Index
2
About
Shian‐Shiang Wang is a leading researcher in the molecular genetics of prostate cancer, with a focused expertise on how long noncoding RNA (lncRNA) polymorphisms influence disease progression and clinical outcomes. His major contributions center on elucidating the role of lncRNAs—specifically MALAT1 and H19—as biomarkers for lymph node metastasis and tumor aggressiveness. In his highly cited 2021 study, Wang demonstrated that MALAT1 polymorphisms are significantly associated with lymph node metastasis in prostate cancer, a finding that has garnered 15 citations and offers a potential genetic tool for refining prognosis. His 2020 work on H19 polymorphisms, with 10 citations, further challenges conventional risk stratification by showing that lncRNA variants can uncover oncologic threats missed by standard PSA levels and Gleason scores. Wang’s research is pivotal for advancing active surveillance strategies, providing a molecular lens to better identify high-risk patients. His work stands at the intersection of genomics and clinical oncology, offering actionable insights for personalized prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2